Straits Research Market

The global cancer supportive care drugs market was valued at approximately USD 20 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2023 to 2030. The increasing prevalence of cancer, rising adoption of combination therapies, and advancements in supportive care drugs are key drivers of market expansion. Definition Cancer supportive care drugs include medications used to prevent or reduce the adverse effects of cancer treatments. This category includes antiemetics, analgesics, hematopoietic agents, bone-modifying agents, and other supportive therapies that enhance cancer treatment outcomes. List of key players in Cancer Supportive Care Drugs Market Amgen Inc Merck & Co.Inc. Johnson & Johnson Services Inc. Heron Therapeutics Inc. Novartis AG Download Free Request Sample Report @  https://straitsresearch.com/report/cancer-supportive-care-drugs-market/request-sample Key Market Drivers Rising Cancer Incidence : The increasing global burd...

The global genome editing market was valued at approximately USD 5.5 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 15.2% from 2023 to 2030. Factors such as increasing demand for gene therapy, rising investments in genomics research, and advancements in gene-editing technologies are driving market expansion. Definition Genome editing refers to the use of molecular tools such as CRISPR-Cas9, TALENs, and ZFNs to alter genetic material with high precision. The market includes products, services, and applications related to gene therapy, drug discovery, agriculture, and synthetic biology. Download Free Request Sample Report @  https://straitsresearch.com/report/genome-editing-market/request-sample Challenges and Opportunities Challenges : Ethical concerns surrounding genetic modifications. Regulatory complexities and evolving legal frameworks. High costs associated with genome-editing technologies. Opportunities : Expansion of gene-editing applicatio...

The global smart health devices market was valued at approximately USD 50 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.8% from 2023 to 2030. The rising adoption of digital health solutions, increasing prevalence of chronic diseases, and advancements in wearable technologies are driving market growth. Definition Smart health devices include wearables, smart medical equipment, and mobile health applications that track various health parameters such as heart rate, blood glucose levels, oxygen saturation, and physical activity. These devices leverage IoT, artificial intelligence (AI), and big data analytics to provide insights into personal health. Download Free Request Sample Report @  https://straitsresearch.com/report/smart-health-devices-market/request-sample Key Market Drivers Increasing Prevalence of Chronic Diseases : Smart health devices assist in managing conditions like diabetes, cardiovascular diseases, and hypertension. Rising Demand...

The global diabetes devices market was valued at approximately USD 28 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030. The increasing prevalence of diabetes, rising healthcare expenditure, and advancements in diabetes management technologies are driving market expansion. Definition The diabetes devices market includes blood glucose monitoring systems, insulin delivery devices, continuous glucose monitors (CGMs), and other related technologies. These devices help individuals with diabetes maintain optimal blood sugar levels and prevent complications. Download Free Request Sample Report @  https://straitsresearch.com/report/diabetes-devices-market/request-sample key players  Medtronic Abbott Ascensia Diabetes Care Holdings AG Hoffmann-La Roche Ltd. Sanofi Novo Nordisk A/S Insulet Corporation Ypsomed Valeritas Inc Challenges and Opportunities Challenges : High costs of advanced diabetes devices. Limited access to diabetes ...

The global breast cancer liquid biopsy market was valued at approximately USD 500 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 23% from 2023 to 2030. The increasing prevalence of breast cancer, advancements in molecular diagnostics, and growing demand for non-invasive diagnostic procedures are driving market expansion. Defination: The breast cancer liquid biopsy market consists of diagnostic technologies and solutions designed to analyze circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and other biomarkers. These tests aid in early detection, treatment selection, disease monitoring, and recurrence detection. Download Free Request Sample Report @  https://straitsresearch.com/report/breast-cancer-liquid-biopsy-market/request-sample Key Players: Biocept Inc. F. Hoffmann-La Roche Ltd. (Foundation Medicine Inc.) Fluxion Biosciences Inc. Menarini Group (Menarini Silicon Biosystems Inc.) Myriad Genetics Inc. NeoGenomics Laboratories Inc....

The global wound debridement market was valued at approximately USD 4.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2030. By 2030, the market is projected to reach USD 6.9 billion. The increasing prevalence of chronic wounds, diabetic ulcers, and the rising geriatric population drive market expansion. Defination: The wound debridement market comprises medical devices, enzymatic debridement agents, mechanical tools, and biological methods used in wound care management. The market serves hospitals, clinics, home healthcare services, and specialized wound care centers. Download Free Request Sample Report @   https://straitsresearch.com/report/wound-debridement-market/request-sample Key Market Drivers Rising Incidence of Chronic Wounds : The growing number of patients with diabetes, pressure ulcers, and venous ulcers is fueling demand for advanced wound care solutions. Technological Advancements : Innovations such as ultrasonic d...

The global maternal mental health market was valued at approximately USD 6.22 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.43% from 2023 to 2030. By 2030, the market is expected to reach USD 45.72 billion. The increasing prevalence of maternal mental health disorders, growing awareness, and technological advancements in mental health solutions are significant factors contributing to this growth. Defination: The maternal mental health market consists of products and services aimed at preventing, diagnosing, and treating mental health disorders affecting pregnant and postpartum women. Key components of this market include pharmaceutical products, therapy services, digital health solutions, and government-funded initiatives. Download Free Request Sample Report @  https://straitsresearch.com/report/maternal-mental-health-market/request-sample List of key players in Maternal Mental Health Market March of Dimes Viatris Inc. GSK plc. Alembic Pharm...

  The global atherectomy devices market is witnessing significant growth, driven by the increasing prevalence of cardiovascular diseases (CVDs), advancements in minimally invasive surgical techniques, and the rising demand for effective plaque removal solutions. As the geriatric population grows and lifestyle diseases such as diabetes and obesity rise, the market for atherectomy devices is expected to expand.  The global atherectomy devices market size was valued at USD 1,054.6 million in 2024 and is projected to grow from USD 1,153.6 million in 2025 to reach USD 1,945.0 million by 2033, exhibiting a CAGR of 6.7% during the forecast period (2025-2033). Defination: Atherectomy devices are specialized medical tools used in minimally invasive procedures to remove atherosclerotic plaque from blood vessels, improving blood flow in patients with peripheral and coronary artery diseases. These devices are essential in treating complex arterial blocka...

The global ophthalmic viscosurgical devices market is experiencing significant growth due to the increasing prevalence of cataracts and glaucoma, advancements in ophthalmic surgical techniques, and the rising demand for minimally invasive eye procedures. The market is projected to expand further with the growing elderly population and increasing awareness of eye health. Defination: Ophthalmic Viscosurgical Devices (OVDs) are viscoelastic substances used in ophthalmic surgeries, particularly in cataract extraction, glaucoma filtration, corneal transplantation, and retinal detachment procedures. These devices help maintain space, protect ocular tissues, and enhance surgical precision during intraocular surgeries. OVDs play a crucial role in improving surgical outcomes and minimizing complications such as endothelial cell loss and post-operative inflammation. Download Free Request Sample Report @  https://straitsresearch.com/report/ophthalmic-viscosurgical-devices-market/request-sampl...

The global membrane chromatography market is experiencing rapid growth due to the increasing demand for biopharmaceuticals, advancements in chromatography techniques, and the rising adoption of single-use technologies in bioprocessing. The market is expected to expand further as biopharmaceutical manufacturers focus on improving efficiency and reducing purification costs.  The global membrane chromatography market size was valued at USD 293.54 million in 2024 and is projected to grow from USD 374.50 million in 2025 to reach USD 1,022.18 million by 2033, growing at a CAGR of 13.4% during the forecast period (2025-2033). Defination: Membrane chromatography is a bioseparation technique that combines the principles of membrane filtration and liquid chromatography to purify biomolecules such as proteins, nucleic acids, and viruses. This method offers high binding capacity, fast processing times, and cost-effectiveness, making it an essential tool in bi...

The global bone wax market is experiencing steady growth due to the increasing number of surgical procedures, rising cases of orthopedic and neurosurgical conditions, and advancements in surgical hemostatic products. With the growing geriatric population and the prevalence of bone-related diseases, the demand for bone wax is expected to rise significantly in the coming years. Defination: Bone wax is a sterile, non-absorbable hemostatic agent used in orthopedic, neurosurgical, and cardiovascular surgeries to control bleeding from bone surfaces. It is composed primarily of beeswax, paraffin, and softening agents, and works by creating a mechanical barrier to prevent further bleeding. Bone wax is commonly utilized in procedures involving the sternum, spinal surgeries, and maxillofacial surgeries to ensure hemostasis. Get Free Exclusive PDF Request Sample Copy of This Research 👉  https://straitsresearch.com/report/bone-wax-market/request-sample Key Market Drivers Rising Number of Orth...

The global blood cancer diagnostics market is witnessing significant growth due to rising blood cancer prevalence, advancements in diagnostic technologies, and increasing awareness of early cancer detection. The market is projected to expand further as precision medicine and biomarker-based testing gain traction in oncology. Defination: Blood cancer diagnostics refer to the medical tests and techniques used to detect, classify, and monitor various types of blood cancers, including leukemia, lymphoma, and multiple myeloma. These diagnostic methods include blood tests, imaging, biopsy, flow cytometry, molecular testing, and next-generation sequencing (NGS). Early and accurate diagnosis is crucial for effective treatment planning and improved patient outcomes. Download Free Request Sample Report @  https://straitsresearch.com/report/blood-cancer-diagnostics-market/request-sample Competitive Landscape Key players in the blood cancer diagnostics market include: Abbott Laboratories F. Ho...

The global pediatric cancer biomarkers market size was valued at USD 905.79 million in 2024 and is projected to grow from USD 995.76 million in 2025 to reach USD 1,737.24 million by 2033, exhibiting a CAGR of 7.20% during the forecast period (2025-2033). The pediatric cancer biomarkers market is witnessing steady growth due to increasing cancer incidence in children, advancements in molecular diagnostics, and the rise of precision medicine. The market is expected to expand further as research and development efforts continue to uncover novel biomarkers for early detection and targeted therapies. Defination: Pediatric cancer biomarkers are biological molecules found in blood, tissue, or other body fluids that indicate the presence, progression, or recurrence of cancer in children. These biomarkers can be proteins, genes, or other molecular signatures that help in early diagnosis, prognosis, and personalized treatment strategies. Pediatric cancer biomark...